Generix Stock Forecast for 2023 - 2025 - 2030
Updated on 05/06/2024
Generix Stock Forecast and Price Target
The average price target for Generix's stock of 11.08€ recently provided by leading analysts would represent a 14.23% upside from its last closing price if reached. This potential increase is based on a high estimate of 12.41€ and a low estimate of 9.86€. Even if you are not interested in GENX stock, it is still crucial to be aware of its competitors.
14.23% Upside
Generix Fair Value Forecast for 2023 - 2025 - 2030
In the last year, Generix's Price has seen an increase, rising from 0.00€ to 0.00€. This represents a growth of 100.00%. Analysts predict that Generix's Fair Value will increase in the upcoming year, reaching 10.52€. This would represent an increase of 100.00%. Over the next six years, experts predict that Generix's Fair Value will grow at a rate of 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| MANH Stock Forecast | Manhattan Associates | Outperform |
16
|
$210.76 | Buy/Sell | $214.81 | 13.87% |
| DSG Stock Forecast | The Descartes Systems Group In... | Outperform |
14
|
C$130.54 | Buy/Sell | C$73.85 | -29.56% |
| SPSC Stock Forecast | SPS Commerce | Outperform |
16
|
$182.41 | Buy/Sell | $192.86 | 12.38% |
| KXS Stock Forecast | Kinaxis | Outperform |
12
|
C$151.38 | Buy/Sell | C$158.67 | -3.59% |
| TCS Stock Forecast | Tecsys | Outperform |
18
|
C$36.00 | Buy/Sell | C$46.40 | 25.00% |
Generix Revenue Forecast for 2023 - 2025 - 2030
In the last two years, Generix's Revenue has seen an increase, rising from 81.10€M to 84.50€M. This represents a growth of 4.19%. In the following year, the 0 analysts surveyed believe that Generix's Revenue will decrease by 3.00%, reaching 81.97€M. According to professionals, by 2030, Generix's Revenue will have decreased by 2.98%, falling down to 81.98€M.
.jpg)
Generix EBITDA Forecast for 2023 - 2025 - 2030
In the last two years, Generix's EBITDA has decreased by 51.69%, from 10.97€M to 5.30€M. In the next year, analysts predict that EBITDA will reach 7.83€M – an increase of 47.74%. For the next eight years, the forecast is for EBITDA to grow by 60.51%.
Generix EBIT Forecast for 2023 - 2025 - 2030
In the last two years, Generix's EBIT has fallen from 9.41€M to 1.20€M – a 87.25% decrease. In the next year, analysts are expecting an increase in EBIT, predicting it will reach 5.02€M – an increase of 318.55%. The Generix forecast is for EBIT to reach 16.16€M or grow by 1247.03%.
Generix EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last year, Generix's EPS has seen an increase, rising from 0.00€ to 0.00€. This represents a growth of 100.00%. Analysts predict that Generix's EPS will increase in the upcoming year, reaching 0.00€. This would represent an increase of 100.00%. Over the next six years, experts predict that Generix's EPS will grow at a rate of 100.00%.
.jpg)